Clinical and Epidemiological Aspects of Invasive Streptococcus pyogenes Infections in Denmark during 2003 and 2004
Top Cited Papers
- 1 January 2008
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (1) , 79-86
- https://doi.org/10.1128/jcm.01626-07
Abstract
Active surveillance of invasive group A streptococcal (GAS) infections was conducted in Denmark during 2003 and 2004 as a part of the Strep-EURO initiative. The main objective was to improve understanding of the epidemiology of invasive GAS disease in Denmark. During the 2 years, 278 cases were reported, corresponding to a mean annual incidence of 2.6 cases per 100,000 inhabitants. The vast majority of isolates, 253 (91%), were from blood, with the remaining 25 (9%) being from cerebrospinal fluid, joints, or other normally sterile sites. The mean case fatality rate (CFR) was 20%, with the rate being higher in patients more than 70 years of age (36.5%). For streptococcal toxic shock syndrome (STSS) and necrotizing fasciitis the CFRs were 53% and 25%, respectively. Out of 16 T types recorded, three predominated: T28 (23%), T1 (22%), and the cluster T3/13/B3264 (14%). Among 29 different emm types, emm28 and emm1 accounted for 51% of strains, followed by emm3 (11%), emm89 (7%), and emm12 (5.5%). Low resistance rates were detected for macrolide-lincosamide-streptogramin B (MLS(B)) antibiotics (3%) and tetracycline (8%); two isolates exhibited coresistance to tetracycline and macrolides. Of nine pyrogenic exotoxin (superantigen) genes examined, speA and speC were identified in 58% and 40% of the strains, respectively; either of the genes was present in all strains causing STSS. Most strains harbored speG (99%). ssa was present in 14% of the isolates only. In Denmark, as in comparable countries, GAS invasive disease shows a sustained, high endemicity, with involvement of both established and emerging streptococcal emm and T types.Keywords
This publication has 63 references indexed in Scilit:
- Molecular and Clinical Characteristics of Invasive Group A Streptococcal Infection in SwedenClinical Infectious Diseases, 2007
- Epidemiological analysis of group A streptococci recovered from patients in ChinaJournal of Medical Microbiology, 2006
- Identification and Characterization of an Antigen I/II Family Protein Produced by Group AStreptococcusInfection and Immunity, 2006
- Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian regionClinical Microbiology & Infection, 2006
- Group A Streptococci from Carriage and Disease in Portugal: Evolution of Antimicrobial Resistance and T Antigenic Types During 2000–2002Microbial Drug Resistance, 2005
- Molecular Characterization ofStreptococcus PyogenesIsolates to investigate an outbreak of Puerperal SepsisInfection Control & Hospital Epidemiology, 2005
- Tetracycline and Macrolide Co-Resistance in Streptococcus pyogenes: Co-Selection As a Reason for Increase in Macrolide-Resistant S. pyogenes?Microbial Drug Resistance, 2004
- Invasive Group A Streptococcal Infections in Ontario, CanadaNew England Journal of Medicine, 1996
- Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin ANew England Journal of Medicine, 1989
- Genetic Variation in the M Antigen of Group A Streptococci: Reassortment of Type-Specific Markers and Possible Antigenic DriftThe Journal of Infectious Diseases, 1979